CIK 0001615219 · Non-accelerated filer<br>Smaller reporting company
Decoy Therapeutics Inc.
Sign in to watch- Ticker
- DCOY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465087339
- Phone
- 346-772-0346
- Business address
- 2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
- Former names
- Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-03 | Arthur David J. Chief Executive Officer | Grant or award | +7,939 | $0.72 | $6K | 110,186 |
| 2021-11-03 | Rosenblum Mark J Exec VP Finance, CFO | Grant or award | +7,787 | $0.72 | $6K | 34,073 |
| 2021-08-17 | Arthur David J. Chief Executive Officer | Purchase | +2,000 | $0.90 | $2K | 100,247 |
| 2021-08-17 | Arthur David J. Chief Executive Officer | Purchase | +2,000 | $0.89 | $2K | 102,247 |
| 2021-08-10 | HANISH ARNOLD C Director | Purchase | +7,000 | $0.88 | $6K | 18,350 |
| 2021-05-03 | Rosenblum Mark J Exec VP Finance, CFO | Grant or award | +9,563 | $0.57 | $5K | 26,286 |
| 2021-05-03 | Arthur David J. Chief Executive Officer | Grant or award | +9,822 | $0.57 | $6K | 96,247 |
| 2020-12-02 | Burleson Tess Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-12-02 | Arthur David J. Chief Executive Officer | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2020-12-02 | McVicar William K. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-12-02 | Rosenblum Mark J Exec VP Finance, CFO | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2020-12-02 | HANISH ARNOLD C Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-12-02 | Lieber Jonathan I Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-12-02 | McCreedy Bruce J Jr. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-12-02 | Lammers Paul Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-11-03 | Arthur David J. Chief Executive Officer | Grant or award | +4,879 | $0.56 | $3K | 86,425 |
| 2020-11-03 | Rosenblum Mark J Exec VP Finance, CFO | Grant or award | +4,723 | $0.56 | $3K | 16,723 |
| 2020-08-21 | HANISH ARNOLD C Director | Purchase | +4,000 | $0.98 | $4K | 11,350 |
| 2020-08-21 | HANISH ARNOLD C Director | Purchase | +4,000 | $0.98 | $4K | 11,350 |
| 2020-08-19 | Arthur David J. Chief Executive Officer | Purchase | +1,000 | $1.01 | $1K | 1,000 |
Page 4 of 6 · 107 trades